Jefferies downgraded Sandoz (SDZNY) to Hold from Buy with a price target of CHF 47.60, up from CHF 42.80. The firm views the post-earnings share rally as “excessive.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- Sandoz Group Reports Strong H1 2025 Financial Results
- Sandoz Group Ltd’s Strategic Growth Amid Market Challenges
- Sandoz to acquire Just-Evotec Biologics from Evotec for $300M
- Sandoz issues recall for additional lot of Cefazolin for injection
- Sandoz breaks ground on new Slovenia facility to expand European biosimilar hub